Following a positive advisory committee meeting outcome regarding the Janssen Biotech Inc. COVID-19 vaccine, the U.S. Food and Drug Administration has informed the sponsor that it will rapidly work toward finalization and issuance of an emergency use authorization
via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3svKxcD
No comments:
Post a Comment